Inhibition by mibefradil, a novel calcium channel antagonist, of Ca(2+)- and volume-activated Cl- channels in macrovascular endothelial cells

British Journal of Pharmacology
B NiliusG Droogmans

Abstract

1. We have studied the effects of mibefradil, a novel calcium antagonist, on the resting potential and ion channel activity of macrovascular endothelial cells (calf pulmonary artery endothelial cells, CPAE). The patch clamp technique was used to measure ionic currents and the Fura-II microfluorescence technique to monitor changes in the intracellular Ca2+ concentration, [Ca2+]i. 2. Mibefradil (10 microM) hyperpolarized the membrane potential of CPAE cells from its mean control value of -26.6 +/- 0.6 mV (n = 7) to -59.8 +/- 1.7 mV (n = 6). A depolarizing effect was observed at higher concentrations (-13.7 +/- 0.6 mV, n = 4, 30 microM mibefradil). 3. Mibefradil inhibited Ca(2+)-activated Cl- currents, ICl,Ca, activated by loading CPAE cells via the patch pipette with 500 nM free Ca2+ (Ki = 4.7 +/- 0.18 microM, n = 8). 4. Mibefradil also inhibited volume-sensitive Cl- currents, ICl,vol, activated by challenging CPAE cells with a 27% hypotonic solution (Ki = 5.4 +/- 0.22 microM, n = 6). 5. The inwardly rectifying K+ channel, IRK, was not affected by mibefradil at concentrations up to 30 microM. 6. Ca2+ entry activated by store depletion, as assessed by the rate of [Ca2+]i-increase upon reapplication of 10 mM extracellular Ca2+ to s...Continue Reading

References

Jun 1, 1992·Pflügers Archiv : European journal of physiology·K Groschner, W R Kukovetz
Aug 1, 1995·Journal of Cardiovascular Pharmacology·C F KüngT F Lüscher
May 1, 1994·The Journal of General Physiology·B NiliusG Droogmans
Jul 1, 1994·Circulation Research·S K Mishra, K Hermsmeyer
Apr 12, 1994·Proceedings of the National Academy of Sciences of the United States of America·M OikeB Nilius
Feb 15, 1994·European Journal of Pharmacology·E Hosoki, T Iijima
Oct 1, 1995·Kidney International·K Strange, P S Jackson
Nov 1, 1995·Pflügers Archiv : European journal of physiology·T VoetsB Nilius
Jan 1, 1996·Journal of Vascular Research·K Hermsmeyer, K Miyagawa
Oct 1, 1996·General Pharmacology·B NiliusG Droogmans
Jan 15, 1997·The Journal of Physiology·B NiliusG Droogmans
Jan 1, 1997·Annual Review of Physiology·B NiliusG Droogmans

❮ Previous
Next ❯

Citations

Jan 12, 2008·Pflügers Archiv : European journal of physiology·Hae Young YooSung Joon Kim
May 1, 2008·Pflügers Archiv : European journal of physiology·Anja Meissner, Thomas Noack
Oct 26, 2000·European Journal of Pharmacology·N C McNaughtonA Randall
Jan 1, 1997·Progress in Biophysics and Molecular Biology·B NiliusG Droogmans
Sep 7, 2000·General Pharmacology·V G ManolopoulosB Nilius
Mar 17, 1999·British Journal of Pharmacology·C MaertensB Nilius
Dec 22, 1999·British Journal of Pharmacology·T MuraiM Watanabe
Nov 18, 2000·British Journal of Pharmacology·S J PotocnikM A Hill
Feb 16, 2005·Annual Review of Physiology·Criss HartzellJorge Arreola
Jan 8, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Fanny M DreyfusNathalie Leresche
Jan 28, 2014·Pflügers Archiv : European journal of physiology·C H Fry, R I Jabr
Jan 11, 2014·Pflügers Archiv : European journal of physiology·Yuan ZhangJin Tao
Sep 18, 2013·Pflügers Archiv : European journal of physiology·Régis C LambertNathalie Leresche
Jan 15, 2009·Canadian Journal of Physiology and Pharmacology·Lars Jørn Jensen, Niels-Henrik Holstein-Rathlou
Nov 13, 2015·Toxicology Letters·Wesley W HolmesDana R Anderson
Jun 5, 2001·The Journal of Physiology·S D KohK M Sanders
Dec 17, 2015·Pflügers Archiv : European journal of physiology·Sebastian SchäferVladimir Chubanov
Jan 18, 2011·The Journal of Pharmacy and Pharmacology·Ren-Hong DuYong-Yuan Guan
Jul 18, 2006·Biochemical and Biophysical Research Communications·Dahai WangKoichi Node
Jan 18, 2006·Biochimica Et Biophysica Acta·Won Jae LeeSarah J Roberts-Thomson
Nov 26, 2014·Oncology Reports·Sen HongChunyan Zhao
Sep 23, 2016·Channels·Nathalie Leresche, Régis C Lambert
Jul 1, 2008·Bioorganic & Medicinal Chemistry Letters·Jae Ho HeoJae Yeol Lee
Jan 6, 2004·Fundamental & Clinical Pharmacology·Alexandra d'Anglemont de TassignyAlain Berdeaux
Jun 5, 2001·Japanese Journal of Pharmacology·T N HeadyE Perez-Reyes
Apr 21, 2001·The Journal of Physiology·R WondergemK E Ferslew
Nov 16, 2002·Circulation Research·Guan-Lei WangYong-Yuan Guan
Dec 21, 2018·Antioxidants & Redox Signaling·Laura Weise-CrossNikki L Jernigan
Mar 25, 2006·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Tetsuya OshimaMasayuki Kambe
Jun 18, 2005·The Journal of Physiology·Sachar Lambert, Johannes Oberwinkler
May 22, 2007·American Journal of Physiology. Heart and Circulatory Physiology·Xavier F FigueroaBrian R Duling
Aug 13, 2013·Pigment Cell & Melanoma Research·Arindam DasCarles Cantí
Jul 20, 2002·Molecular Pharmacology·Gabriel E BertolesiMelanie E M Kelly
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·John J BorgRoland Z Kozlowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.